National Guidelines on the Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT)
- PMID: 35575598
National Guidelines on the Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT)
Abstract
Aim Outpatient parenteral antimicrobial therapy (OPAT) is an option in patients who require parenteral antimicrobial administration and are clinically well enough for hospital discharge. This is an update of the Irish National OPAT guidelines which were last reviewed in 2011. Methods The guideline was devised through a collaborative process with the national OPAT Working Group and a review of the literature. It is intended for clinicians who prescribe any intravenous (IV) antimicrobials outside of the inpatient setting in the Republic of Ireland. Results Patient care while on OPAT should be provided by a designated OPAT service, with clear managerial and clinical governance lines of responsibility. It should be conducted using a team approach with a clinical lead on each site either as an infection specialist, or a general medical physician with infection specialist input and an OPAT nurse. An antimicrobial pharmacist is also desirable. Several factors must be considered when assessing patient's suitability for OPAT including exclusion criteria, infection-specific factors, and patient specific factors such as physical, social and logistic criteria. Conclusion This updated guideline advocates a more individualised OPAT approach, with the recognition that specific antimicrobials and/or specific delivery models may be more appropriate for certain patient groups. Full guidelines are available through www.opat.ie.
Similar articles
-
Optimization of a model of out-of-hospital antibiotic therapy (OPAT) in a Belgian university hospital resulting in a proposal for national implementation.Acta Clin Belg. 2016 Oct;71(5):297-302. doi: 10.1080/17843286.2016.1183285. Epub 2016 May 19. Acta Clin Belg. 2016. PMID: 27203290
-
Dedicated paediatric Outpatient Parenteral Antimicrobial Therapy medical support: a pre-post observational study.Arch Dis Child. 2018 Feb;103(2):165-169. doi: 10.1136/archdischild-2017-313071. Epub 2017 Aug 28. Arch Dis Child. 2018. PMID: 28847879
-
Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.Ther Adv Infect Dis. 2023 Dec 13;10:20499361231214901. doi: 10.1177/20499361231214901. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 38127471 Free PMC article.
-
Recent innovations and new applications of outpatient parenteral antimicrobial therapy.Expert Rev Anti Infect Ther. 2021 Jan;19(1):55-64. doi: 10.1080/14787210.2020.1810566. Epub 2020 Dec 17. Expert Rev Anti Infect Ther. 2021. PMID: 32799577 Review.
-
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23. J Antimicrob Chemother. 2015. PMID: 25538169 Review.
Cited by
-
Consensus-based development and practice testing of a generic quality indicator set for parenteral medication administration at home: a RAND appropriateness method study.BMJ Open. 2025 Jul 1;15(7):e090496. doi: 10.1136/bmjopen-2024-090496. BMJ Open. 2025. PMID: 40592752 Free PMC article.
-
A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.Heliyon. 2023 Apr 11;9(4):e15212. doi: 10.1016/j.heliyon.2023.e15212. eCollection 2023 Apr. Heliyon. 2023. PMID: 37113779 Free PMC article.
-
Outpatient parenteral antimicrobial therapy (OPAT) for the management of periprosthetic joint infections in the Republic of Ireland (ROI) from 2013 to 2021.IJID Reg. 2024 Oct 11;13:100466. doi: 10.1016/j.ijregi.2024.100466. eCollection 2024 Dec. IJID Reg. 2024. PMID: 39526192 Free PMC article.
-
Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn?JAC Antimicrob Resist. 2024 Jul 19;6(4):dlae111. doi: 10.1093/jacamr/dlae111. eCollection 2024 Aug. JAC Antimicrob Resist. 2024. PMID: 39035018 Free PMC article. Review.
-
Discharge-delaying factors for patients suitable for outpatient parenteral antimicrobial therapy (OPAT) in an Irish tertiary hospital during COVID-19.JAC Antimicrob Resist. 2021 Oct 14;3(4):dlab163. doi: 10.1093/jacamr/dlab163. eCollection 2021 Dec. JAC Antimicrob Resist. 2021. PMID: 34661108 Free PMC article. No abstract available.